Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

Generic Drugs Face Regulatory and Scientific Challenges

FDA funds research to further development of innovative generics.
Aug 2, 2013

FDA funds research to further development of innovative generics, while working to address review and approval issues.

Regulatory Roundup

Compounding, tracking legislation moves forward
Jul 2, 2013

Compounding, tracking legislation moves forward

FDA Urges Greater Focus on Contractor Quality

Outsourcing requires clear policies and written agreements with CMOs.
Jul 2, 2013

Increased manufacturer outsourcing requires clear policies and written agreements with CMOs.

Regulatory Roundup

An overview of the latest regulatory developments for malaria drugs, biosimilars, and global standards.
Jun 2, 2013

An overview of the latest regulatory developments for malaria drugs, biosimilars, and global standards.

Congress Considers Legislation to Secure Drug Supply Chain

Bills to regulate drug compounding and establish a national track and trace system face political and policy differences.
Jun 2, 2013

Bills to regulate drug compounding and establish a national track and trace system face political and policy differences.

Regulatory Roundup

May 2, 2013

FDA faces budget crunch; Supreme Court hears key cases

Regulatory Convergence Sought for Global Pharma Market

Manufacturers work with international authorities to harmonize drug registration and supply-chain oversight.
May 2, 2013

Manufacturers work with international authorities to harmonize drug registration and supply-chain oversight.

Regulatory Roundup

Latest news about compound pharmacies, biosimilars, prescription drug purchases, and other regulatory topics.
Apr 2, 2013

Latest news about compound pharmacies, biosimilars, prescription drug purchases, and other regulatory topics.

Manufacturers Under Pressure to Manage Painkillers

Opioid abuse generates calls for efforts to curb distribution, develop abuse-resistant formulations.
Apr 2, 2013

Opioid abuse generates calls for efforts to curb distribution, develop abuse-resistant formulations.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
10%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
8%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here